U.S. Hemostasis Valve Market Size Worth USD 116.33 Million by 2034 | CAGR: 5.6%

The U.S. hemostasis valve market size is expected to reach USD 116.33 million by 2034, according to a new study by Polaris Market Research. The report “U.S. Hemostasis Valve Market Size, Share, Trends, Industry Analysis Report By Type (Hemostasis Valve Y- Connectors, Double Y- Connector Hemostasis Valves), By Application, By End Use; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

A hemostasis valve is a medical device used during catheter-based interventional procedures to prevent blood loss while allowing instruments to pass through vascular access sites.

The U.S. healthcare system is rapidly shifting toward minimally invasive surgery to reduce recovery time, hospital stays, and procedural complications. Interventional radiology and cardiology techniques are replacing traditional open surgeries, and these catheter-based approaches rely heavily on devices such as hemostasis valves to maintain blood control. The demand for tools that support these procedures is increasing as patient preference and healthcare policies favor less invasive care. Hemostasis valves are integral to ensuring both patient safety and procedural success in these fast-growing segments, making them a key component of the modern U.S. clinical toolkit and driving the U.S. hemostasis valve market market growth.

Bottom of Form

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/us-hemostasis-valve-market/request-for-sample

Medical institutions in the U.S. invest heavily in training programs and continuing education for healthcare professionals, especially in fields such as interventional cardiology, radiology, and endovascular surgery. These programs emphasize safe and efficient vascular access techniques, which include the use of hemostasis valves. The preference for high-quality valve solutions that improve procedural control and reduce complications such as blood loss and infection rise as clinical awareness grows. The educated and skilled medical workforce in the U.S. ensures high adoption rates of advanced medical devices and supports the ongoing expansion of the hemostasis valve market across various care settings.

U.S. Hemostasis Valve Market Report Highlights

• In 2024, the hospital segment dominated with the largest share due to their advanced infrastructure, access to high patient volumes, and integration of interventional care units.
• The angioplasty segment is expected to experience significant growth during the forecast period as angioplasty remains one of the most commonly performed interventional procedures in the U.S., especially for treating coronary artery disease.
• A few key market players are Abbott; Antmed Corporation; Argon Medical Devices; B. Braun Melsungen AG; Boston Scientific Corporation; Lepu Medical Technology (Beijing) Co., Ltd.; Merit Medical Systems; Nipro; SCW Medicath Ltd.; Teleflex Incorporated; and TERUMO CORPORATION.

Polaris Market Research has segmented the U.S. hemostasis valve market report based on type, application, and end use:

By Type (Revenue - USD Million, 2020–2034)

• Hemostasis Valve Y- Connectors
• Double Y- Connector Hemostasis Valves
• One- Handed Hemostasis Valves
• Others

By Application (Revenue - USD Million, 2020–2034)

• Angiography
• Angioplasty

By End Use (Revenue - USD Million, 2020–2034)

• Hospitals
• Ambulatory Surgical Centers
• Others